Magnetic Resonance Spectroscopy: An Objective Technique for the Quantification of Prostate Cancer Pathologies
Abstract
In the past year, the three years of the award, according to our proposed Statement of Work, we continued our efforts on the collection of specimens from prostate cancer patients, and spectroscopic and histopathological measurements of these samples for the construction of metabolic markers aimed at tumor diagnosis based on HRMAS 1HMR evaluation. Significant progresses have been achieved. Three peer-reviewed papers from the project have been published, and one new manuscript has been submitted. In addition, two peer-reviewed review articles and one book chapter are currently in pending for publication, and one patent application as the results of the direct funding support from this award. Furthermore, two NIH grants have been submitted as a direct result of researches supported by this award. These advancements will assist us to better understand tumor metabolism observed with MR spectroscopy, and contribute to better patient cares in the future.
Document Details
- Document Type
- Technical Report
- Publication Date
- Feb 01, 2007
- Accession Number
- ADA470689
Entities
People
- Leo L. Cheng
Organizations
- Massachusetts General Hospital